Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma

Introduction. Malignant Pleural Mesothelioma (MPM) is a rare disease, even less frequently described in minority patients. We used a large population-based dataset to study the role of race in MPM presentation, treatment, and survival. Methods. All cases of pathologically proven MPM were identified...

Full description

Bibliographic Details
Main Authors: Taioli, Emanuela, Wolf, Andrea S., Moline, Jacqueline M., Camacho-Rivera, Marlene, Flores, Raja M.
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430630/
id pubmed-4430630
recordtype oai_dc
spelling pubmed-44306302015-06-10 Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma Taioli, Emanuela Wolf, Andrea S. Moline, Jacqueline M. Camacho-Rivera, Marlene Flores, Raja M. Research Article Introduction. Malignant Pleural Mesothelioma (MPM) is a rare disease, even less frequently described in minority patients. We used a large population-based dataset to study the role of race in MPM presentation, treatment, and survival. Methods. All cases of pathologically proven MPM were identified in the Surveillance, Epidemiology, and End Results (SEER) database. Age, sex, diagnosis year, stage, cancer-directed surgery, radiation, and vital status were analyzed according to self-reported race (black or white). Results. There were 13,046 white and 688 black MPM patients (incidence: 1.1 per 100,000 whites; 0.5 per 100,000 blacks; age-adjusted, p = 0.01). Black patients were more likely to be female, younger, and with advanced stage and less likely to undergo cancer-directed surgery than whites, after adjustment by stage. On multivariable analysis, younger age and having surgery were associated with longer survival for both cohorts; female gender (HR 0.82 (0.77–0.88)) and early stage at diagnosis (HR 0.83 (0.76–0.90)) were predictive of longer survival in white, but not in black, patients. Conclusions. Surgery was associated with improved survival for both black and white MPM patients. However, black patients were less likely to undergo cancer-directed surgery. Increased surgical intervention in MPM black patients with early stage disease may improve their survival. Hindawi Publishing Corporation 2015 2015-04-30 /pmc/articles/PMC4430630/ /pubmed/26063951 http://dx.doi.org/10.1155/2015/282145 Text en Copyright © 2015 Emanuela Taioli et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Taioli, Emanuela
Wolf, Andrea S.
Moline, Jacqueline M.
Camacho-Rivera, Marlene
Flores, Raja M.
spellingShingle Taioli, Emanuela
Wolf, Andrea S.
Moline, Jacqueline M.
Camacho-Rivera, Marlene
Flores, Raja M.
Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
author_facet Taioli, Emanuela
Wolf, Andrea S.
Moline, Jacqueline M.
Camacho-Rivera, Marlene
Flores, Raja M.
author_sort Taioli, Emanuela
title Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
title_short Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
title_full Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
title_fullStr Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
title_full_unstemmed Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
title_sort frequency of surgery in black patients with malignant pleural mesothelioma
description Introduction. Malignant Pleural Mesothelioma (MPM) is a rare disease, even less frequently described in minority patients. We used a large population-based dataset to study the role of race in MPM presentation, treatment, and survival. Methods. All cases of pathologically proven MPM were identified in the Surveillance, Epidemiology, and End Results (SEER) database. Age, sex, diagnosis year, stage, cancer-directed surgery, radiation, and vital status were analyzed according to self-reported race (black or white). Results. There were 13,046 white and 688 black MPM patients (incidence: 1.1 per 100,000 whites; 0.5 per 100,000 blacks; age-adjusted, p = 0.01). Black patients were more likely to be female, younger, and with advanced stage and less likely to undergo cancer-directed surgery than whites, after adjustment by stage. On multivariable analysis, younger age and having surgery were associated with longer survival for both cohorts; female gender (HR 0.82 (0.77–0.88)) and early stage at diagnosis (HR 0.83 (0.76–0.90)) were predictive of longer survival in white, but not in black, patients. Conclusions. Surgery was associated with improved survival for both black and white MPM patients. However, black patients were less likely to undergo cancer-directed surgery. Increased surgical intervention in MPM black patients with early stage disease may improve their survival.
publisher Hindawi Publishing Corporation
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430630/
_version_ 1613223094009200640